"This research highlights the potential for aerobic exercise to serve as a cornerstone in preventive strategies for Alzheimer ...

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer's-related psychosis during the ...

Researchers at the University of Kentucky (UK) are part of a groundbreaking clinical trial exploring the use of medical ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Mild chronic small vessel disease, or cerebral small vessel disease (CSVD), is an umbrella term for a range of conditions ...

Dementia rates in the U.S. could double by 2060 to a million new cases per year, according to a study published on Monday.

Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease ...

Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...